NCT00580684View on ClinicalTrials.gov

Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

August 31, 2004

Conditions
Vaccines, PneumococcalVaccines, Pneumococcal Conjugate Vaccine
Interventions
BIOLOGICAL

pneumococcus conjugate vaccine 7 valent to reduce carriage

plain polisacaride vaccine 23 valent to reduce carriage

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00580684 - Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children | Biotech Hunter | Biotech Hunter